Filing Details

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) BioAmber Inc. (Name of Issuer) Common (Title of Class of Securities) 09072Q106 (CUSIP Number) December 31, 2017 Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is filed: X Rule 13d-1(b) ? Rule 13d-1(c) ? Rule 13d-1(d) The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 09072Q106 1 Name of reporting person S.S. or I.R.S. Identification No. of Above Person CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.2 Check the appropriate box if a member of a group (a)(b) ?3 SEC USE ONLY 4 Citizenship or place of organization Vancouver, British Columbia, Canada 5 Sole Voting Power Number of Shares 0 Beneficially 6 Shared Voting Power owned by each reporting 7 Sole Dispositive Power person with 0 8 Shared Dispositive Power 9 Aggregate amount beneficially owned by each reporting person Connor, Clark & Lunn Investment Management Ltd. 0 10 Check box if the aggregate amount in row (9) excludes certain shares* Not Applicable 11 Percent of Class Represented by amount in Row 9 Connor, Clark & Lunn Investment Management Ltd. 0.0% 12 Type of Reporting* IA (Investment Adviser)